A

Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS

Watchlist Manager
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Watchlist
Price: 539.5 INR 2.03% Market Closed
Market Cap: ₹82.6B

Akums Drugs and Pharmaceuticals Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Akums Drugs and Pharmaceuticals Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
A
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Free Cash Flow
₹1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Free Cash Flow
₹540m
CAGR 3-Years
-71%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Free Cash Flow
₹2B
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
N/A
O
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Free Cash Flow
-₹2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sai Life Sciences Ltd
NSE:SAILIFE
Free Cash Flow
-₹552.4m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Anthem Biosciences Ltd
NSE:ANTHEM
Free Cash Flow
₹1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Akums Drugs and Pharmaceuticals Ltd
Glance View

Akums Drugs and Pharmaceuticals Ltd., an unsung hero within India's healthcare sector, crafts its narrative through a robust commitment to pharmaceutical manufacturing. Founded in 2004, this company quietly emerged as a formidable provider of contract drug manufacturing solutions. Instead of marketing its own branded products, Akums positions itself as the silent partner behind many well-known pharmaceutical names, providing vital production services. By offering end-to-end manufacturing, from raw material sourcing to finished product packaging, Akums ensures that pharmaceutical companies can concentrate on their strengths: marketing and distribution. The company thrives on its vast portfolio, which encompasses the manufacture of nearly every form of a pharmaceutical product—be it tablets, capsules, injectables, or topical treatments. Akums drives revenue through partnerships, where it functions as the backbone of production lines for its clients. Utilizing cutting-edge technology and stringent global standards, Akums not only addresses the varied needs of the pharmaceutical industry but also adapts to the ever-evolving demands of healthcare worldwide. This strategic focus on high-quality contract manufacturing fuels its financial success, allowing it to expand facilities and scale operations, while maintaining a discreet presence that underscores its core philosophy: to innovate in service rather than spotlight.

AKUMS Intrinsic Value
479.02 INR
Overvaluation 11%
Intrinsic Value
Price ₹539.5
A

See Also

What is Akums Drugs and Pharmaceuticals Ltd's Free Cash Flow?
Free Cash Flow
1.9B INR

Based on the financial report for Mar 31, 2025, Akums Drugs and Pharmaceuticals Ltd's Free Cash Flow amounts to 1.9B INR.

What is Akums Drugs and Pharmaceuticals Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
3%

Over the last year, the Free Cash Flow growth was 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett